Document is current
Any future updates will be listed below
-
Authors
McKay, R R
Zukotynski, K A
Werner, L
Voznesensky, O
Wu, J S
Smith, S E
Jiang, Z
Melnick, K
Yuan, X
Kantoff, P W
Montgomery, B
Balk, S P
Taplin, M-E
- License Information
-
More Information
Article History
Received: 27 March 2014
Revised: 22 May 2014
Accepted: 16 June 2014
First Online: 5 August 2014
Competing interests
: Dr Taplin has received research funding for clinical trials of abiraterone from Janssen and has an advisory role at Janssen. The remaining authors declare no conflict of interest.
